When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AMPE - Ampio to study nebulized Ampion as a treatment for COVID-19
Ampio Pharmaceuticals Inc.
Ampio Pharmaceuticals (NYSEMKT:AMPE) is preparing an expanded access FDA protocol to study potential benefit of nebulized treatment with Ampion in SARS-Cov-2 induced Acute Respiratory Distress Syndrome ("ARDS"), an immediately life-threatening condition.
More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news,